Advertorials
Quality and Conduct in China: Why Leadership Behaviour Is the Real Differentiator
China has become a cornerstone of global clinical development Regulatory reform expanding investigator expertise and the scale of its healthcare system have made the country integral to multinational trials But as Chinas role grows so does scrutiny around quality data integrity and ethical conduct
The Evolution of Bioprocessing
Bridging Global Expertise with Local Innovation
In the rapidly advancing landscape of biopharmaceuticals the demand for highquality recombinant proteins and antibodies
A New Chapter in PROCOS’ Growth Journey
PROCOS Advances Its Expansion Strategy With a New Production Building and Continues Its Sustainability Commitment
PROCOS SpA stands as one of the historical players in the pharmaceutical industry known for its excellence in the development
Revolutionizing Drug Discovery
Advancing Metabolite Identification with LC-MS and EAD
Liquid ChromatographyMass Spectrometry LCMS has emerged as one of the most powerful and versatile tools
Accelerating Biomarker Discovery Assays
Biomarker analysis is pivotal in modern drug discovery and development boosting therapeutic success rates
High, Higher, HighCon
The pharmaceutical industry is in a constant race against time New diseases are always developing that require
Why small parcel shipments are a growing priority for contract pharma
The pharmaceutical industry continues to navigate rapid transformation driven by innovation in treatment delivery
The Human Machine
A Patient-Centric View on Pharma’s Tech-Led Future
Imagine a world where medications could be precisely tailored to each individual patient where doctors
Characterizing AAV Capsids with Label-Free Biosensor Technology
The adoption of BLI has brought two major improvements to our analyses compared to traditional techniques like
Genomic Editing: Transforming the Future of Pharmaceuticals
Sponsored by Sartorius
Genomic editing is at the cutting edge of a revolutionary period in medicine especially in the drug industry Genomic editing has been nominated by some to be one of the most dangerous technologies given the potential allowed by such tools as CRISPR Clustered Regularly Interspaced Short Palindromic Repeats Cas Transcription activatorlike effector n...
